The association of this specific variant with cardiomyopathy in our study underscores a direct clinical link between GJB4 mutations and significant cardiac phenotypes beyond PFO, suggesting that carriers of this variant, particularly in the Tibetan population, may warrant closer cardiac monitoring for potential functional impairment. This evidence concerns the gene GJB4 and cardiomyopathy.